2 million new cases world wide of breast cancer of which 10-20% are diagnosed as TNBC. If you split the difference to 15%, that's 300,000 new TNBC cases per year, if treated at an OncoSec price tag of just $20k per patient, that's a potential market of $6 billion. That might help with OncoSec's PPS.